Medical Care
Global Post-Traumatic Stress Disorder Treatment Market Research Report 2024
- Jan 29, 24
- ID: 49751
- Pages: 77
- Figures: 145
- Views: 28
The main treatments for post-traumatic stress disorder (PTSD) are psychological therapies and medication.
The global Post-Traumatic Stress Disorder Treatment market was valued at US$ 2410.2 million in 2023 and is anticipated to reach US$ 3135.3 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Post-Traumatic Stress Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post-Traumatic Stress Disorder Treatment.
Report Scope
The Post-Traumatic Stress Disorder Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Post-Traumatic Stress Disorder Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Post-Traumatic Stress Disorder Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer, Inc.
GlaxoSmithKline plc
Otsuka Pharmaceutical Co., Ltd
Novartis AG
AstraZeneca Plc
Azevan Pharmaceuticals, Inc.
Bionomics Ltd.
Tonix Pharmaceuticals Holding Corp.
Apotex, Inc.
Segment by Type
Antidepressants
Anti-Anxiety Drugs
Others
Segment by Application
Hospitals
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Post-Traumatic Stress Disorder Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Post-Traumatic Stress Disorder Treatment market was valued at US$ 2410.2 million in 2023 and is anticipated to reach US$ 3135.3 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Post-Traumatic Stress Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post-Traumatic Stress Disorder Treatment.
Report Scope
The Post-Traumatic Stress Disorder Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Post-Traumatic Stress Disorder Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Post-Traumatic Stress Disorder Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer, Inc.
GlaxoSmithKline plc
Otsuka Pharmaceutical Co., Ltd
Novartis AG
AstraZeneca Plc
Azevan Pharmaceuticals, Inc.
Bionomics Ltd.
Tonix Pharmaceuticals Holding Corp.
Apotex, Inc.
Segment by Type
Antidepressants
Anti-Anxiety Drugs
Others
Segment by Application
Hospitals
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Post-Traumatic Stress Disorder Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Post-Traumatic Stress Disorder Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antidepressants
1.2.3 Anti-Anxiety Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Post-Traumatic Stress Disorder Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Post-Traumatic Stress Disorder Treatment Market Perspective (2019-2030)
2.2 Post-Traumatic Stress Disorder Treatment Growth Trends by Region
2.2.1 Global Post-Traumatic Stress Disorder Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Post-Traumatic Stress Disorder Treatment Historic Market Size by Region (2019-2024)
2.2.3 Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Region (2025-2030)
2.3 Post-Traumatic Stress Disorder Treatment Market Dynamics
2.3.1 Post-Traumatic Stress Disorder Treatment Industry Trends
2.3.2 Post-Traumatic Stress Disorder Treatment Market Drivers
2.3.3 Post-Traumatic Stress Disorder Treatment Market Challenges
2.3.4 Post-Traumatic Stress Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Post-Traumatic Stress Disorder Treatment Players by Revenue
3.1.1 Global Top Post-Traumatic Stress Disorder Treatment Players by Revenue (2019-2024)
3.1.2 Global Post-Traumatic Stress Disorder Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Post-Traumatic Stress Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Post-Traumatic Stress Disorder Treatment Revenue
3.4 Global Post-Traumatic Stress Disorder Treatment Market Concentration Ratio
3.4.1 Global Post-Traumatic Stress Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Post-Traumatic Stress Disorder Treatment Revenue in 2023
3.5 Post-Traumatic Stress Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Post-Traumatic Stress Disorder Treatment Product Solution and Service
3.7 Date of Enter into Post-Traumatic Stress Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Post-Traumatic Stress Disorder Treatment Breakdown Data by Type
4.1 Global Post-Traumatic Stress Disorder Treatment Historic Market Size by Type (2019-2024)
4.2 Global Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Type (2025-2030)
5 Post-Traumatic Stress Disorder Treatment Breakdown Data by Application
5.1 Global Post-Traumatic Stress Disorder Treatment Historic Market Size by Application (2019-2024)
5.2 Global Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Post-Traumatic Stress Disorder Treatment Market Size (2019-2030)
6.2 North America Post-Traumatic Stress Disorder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Post-Traumatic Stress Disorder Treatment Market Size by Country (2019-2024)
6.4 North America Post-Traumatic Stress Disorder Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Post-Traumatic Stress Disorder Treatment Market Size (2019-2030)
7.2 Europe Post-Traumatic Stress Disorder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Post-Traumatic Stress Disorder Treatment Market Size by Country (2019-2024)
7.4 Europe Post-Traumatic Stress Disorder Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size (2019-2030)
8.2 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Post-Traumatic Stress Disorder Treatment Market Size (2019-2030)
9.2 Latin America Post-Traumatic Stress Disorder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Post-Traumatic Stress Disorder Treatment Market Size by Country (2019-2024)
9.4 Latin America Post-Traumatic Stress Disorder Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size (2019-2030)
10.2 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Company Detail
11.1.2 Pfizer, Inc. Business Overview
11.1.3 Pfizer, Inc. Post-Traumatic Stress Disorder Treatment Introduction
11.1.4 Pfizer, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
11.1.5 Pfizer, Inc. Recent Development
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Detail
11.2.2 GlaxoSmithKline plc Business Overview
11.2.3 GlaxoSmithKline plc Post-Traumatic Stress Disorder Treatment Introduction
11.2.4 GlaxoSmithKline plc Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
11.2.5 GlaxoSmithKline plc Recent Development
11.3 Otsuka Pharmaceutical Co., Ltd
11.3.1 Otsuka Pharmaceutical Co., Ltd Company Detail
11.3.2 Otsuka Pharmaceutical Co., Ltd Business Overview
11.3.3 Otsuka Pharmaceutical Co., Ltd Post-Traumatic Stress Disorder Treatment Introduction
11.3.4 Otsuka Pharmaceutical Co., Ltd Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
11.3.5 Otsuka Pharmaceutical Co., Ltd Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Post-Traumatic Stress Disorder Treatment Introduction
11.4.4 Novartis AG Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
11.4.5 Novartis AG Recent Development
11.5 AstraZeneca Plc
11.5.1 AstraZeneca Plc Company Detail
11.5.2 AstraZeneca Plc Business Overview
11.5.3 AstraZeneca Plc Post-Traumatic Stress Disorder Treatment Introduction
11.5.4 AstraZeneca Plc Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
11.5.5 AstraZeneca Plc Recent Development
11.6 Azevan Pharmaceuticals, Inc.
11.6.1 Azevan Pharmaceuticals, Inc. Company Detail
11.6.2 Azevan Pharmaceuticals, Inc. Business Overview
11.6.3 Azevan Pharmaceuticals, Inc. Post-Traumatic Stress Disorder Treatment Introduction
11.6.4 Azevan Pharmaceuticals, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
11.6.5 Azevan Pharmaceuticals, Inc. Recent Development
11.7 Bionomics Ltd.
11.7.1 Bionomics Ltd. Company Detail
11.7.2 Bionomics Ltd. Business Overview
11.7.3 Bionomics Ltd. Post-Traumatic Stress Disorder Treatment Introduction
11.7.4 Bionomics Ltd. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
11.7.5 Bionomics Ltd. Recent Development
11.8 Tonix Pharmaceuticals Holding Corp.
11.8.1 Tonix Pharmaceuticals Holding Corp. Company Detail
11.8.2 Tonix Pharmaceuticals Holding Corp. Business Overview
11.8.3 Tonix Pharmaceuticals Holding Corp. Post-Traumatic Stress Disorder Treatment Introduction
11.8.4 Tonix Pharmaceuticals Holding Corp. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
11.8.5 Tonix Pharmaceuticals Holding Corp. Recent Development
11.9 Apotex, Inc.
11.9.1 Apotex, Inc. Company Detail
11.9.2 Apotex, Inc. Business Overview
11.9.3 Apotex, Inc. Post-Traumatic Stress Disorder Treatment Introduction
11.9.4 Apotex, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
11.9.5 Apotex, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Post-Traumatic Stress Disorder Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antidepressants
1.2.3 Anti-Anxiety Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Post-Traumatic Stress Disorder Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Post-Traumatic Stress Disorder Treatment Market Perspective (2019-2030)
2.2 Post-Traumatic Stress Disorder Treatment Growth Trends by Region
2.2.1 Global Post-Traumatic Stress Disorder Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Post-Traumatic Stress Disorder Treatment Historic Market Size by Region (2019-2024)
2.2.3 Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Region (2025-2030)
2.3 Post-Traumatic Stress Disorder Treatment Market Dynamics
2.3.1 Post-Traumatic Stress Disorder Treatment Industry Trends
2.3.2 Post-Traumatic Stress Disorder Treatment Market Drivers
2.3.3 Post-Traumatic Stress Disorder Treatment Market Challenges
2.3.4 Post-Traumatic Stress Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Post-Traumatic Stress Disorder Treatment Players by Revenue
3.1.1 Global Top Post-Traumatic Stress Disorder Treatment Players by Revenue (2019-2024)
3.1.2 Global Post-Traumatic Stress Disorder Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Post-Traumatic Stress Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Post-Traumatic Stress Disorder Treatment Revenue
3.4 Global Post-Traumatic Stress Disorder Treatment Market Concentration Ratio
3.4.1 Global Post-Traumatic Stress Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Post-Traumatic Stress Disorder Treatment Revenue in 2023
3.5 Post-Traumatic Stress Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Post-Traumatic Stress Disorder Treatment Product Solution and Service
3.7 Date of Enter into Post-Traumatic Stress Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Post-Traumatic Stress Disorder Treatment Breakdown Data by Type
4.1 Global Post-Traumatic Stress Disorder Treatment Historic Market Size by Type (2019-2024)
4.2 Global Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Type (2025-2030)
5 Post-Traumatic Stress Disorder Treatment Breakdown Data by Application
5.1 Global Post-Traumatic Stress Disorder Treatment Historic Market Size by Application (2019-2024)
5.2 Global Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Post-Traumatic Stress Disorder Treatment Market Size (2019-2030)
6.2 North America Post-Traumatic Stress Disorder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Post-Traumatic Stress Disorder Treatment Market Size by Country (2019-2024)
6.4 North America Post-Traumatic Stress Disorder Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Post-Traumatic Stress Disorder Treatment Market Size (2019-2030)
7.2 Europe Post-Traumatic Stress Disorder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Post-Traumatic Stress Disorder Treatment Market Size by Country (2019-2024)
7.4 Europe Post-Traumatic Stress Disorder Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size (2019-2030)
8.2 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Post-Traumatic Stress Disorder Treatment Market Size (2019-2030)
9.2 Latin America Post-Traumatic Stress Disorder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Post-Traumatic Stress Disorder Treatment Market Size by Country (2019-2024)
9.4 Latin America Post-Traumatic Stress Disorder Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size (2019-2030)
10.2 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Company Detail
11.1.2 Pfizer, Inc. Business Overview
11.1.3 Pfizer, Inc. Post-Traumatic Stress Disorder Treatment Introduction
11.1.4 Pfizer, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
11.1.5 Pfizer, Inc. Recent Development
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Detail
11.2.2 GlaxoSmithKline plc Business Overview
11.2.3 GlaxoSmithKline plc Post-Traumatic Stress Disorder Treatment Introduction
11.2.4 GlaxoSmithKline plc Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
11.2.5 GlaxoSmithKline plc Recent Development
11.3 Otsuka Pharmaceutical Co., Ltd
11.3.1 Otsuka Pharmaceutical Co., Ltd Company Detail
11.3.2 Otsuka Pharmaceutical Co., Ltd Business Overview
11.3.3 Otsuka Pharmaceutical Co., Ltd Post-Traumatic Stress Disorder Treatment Introduction
11.3.4 Otsuka Pharmaceutical Co., Ltd Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
11.3.5 Otsuka Pharmaceutical Co., Ltd Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Post-Traumatic Stress Disorder Treatment Introduction
11.4.4 Novartis AG Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
11.4.5 Novartis AG Recent Development
11.5 AstraZeneca Plc
11.5.1 AstraZeneca Plc Company Detail
11.5.2 AstraZeneca Plc Business Overview
11.5.3 AstraZeneca Plc Post-Traumatic Stress Disorder Treatment Introduction
11.5.4 AstraZeneca Plc Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
11.5.5 AstraZeneca Plc Recent Development
11.6 Azevan Pharmaceuticals, Inc.
11.6.1 Azevan Pharmaceuticals, Inc. Company Detail
11.6.2 Azevan Pharmaceuticals, Inc. Business Overview
11.6.3 Azevan Pharmaceuticals, Inc. Post-Traumatic Stress Disorder Treatment Introduction
11.6.4 Azevan Pharmaceuticals, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
11.6.5 Azevan Pharmaceuticals, Inc. Recent Development
11.7 Bionomics Ltd.
11.7.1 Bionomics Ltd. Company Detail
11.7.2 Bionomics Ltd. Business Overview
11.7.3 Bionomics Ltd. Post-Traumatic Stress Disorder Treatment Introduction
11.7.4 Bionomics Ltd. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
11.7.5 Bionomics Ltd. Recent Development
11.8 Tonix Pharmaceuticals Holding Corp.
11.8.1 Tonix Pharmaceuticals Holding Corp. Company Detail
11.8.2 Tonix Pharmaceuticals Holding Corp. Business Overview
11.8.3 Tonix Pharmaceuticals Holding Corp. Post-Traumatic Stress Disorder Treatment Introduction
11.8.4 Tonix Pharmaceuticals Holding Corp. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
11.8.5 Tonix Pharmaceuticals Holding Corp. Recent Development
11.9 Apotex, Inc.
11.9.1 Apotex, Inc. Company Detail
11.9.2 Apotex, Inc. Business Overview
11.9.3 Apotex, Inc. Post-Traumatic Stress Disorder Treatment Introduction
11.9.4 Apotex, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
11.9.5 Apotex, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Post-Traumatic Stress Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antidepressants
Table 3. Key Players of Anti-Anxiety Drugs
Table 4. Key Players of Others
Table 5. Global Post-Traumatic Stress Disorder Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Post-Traumatic Stress Disorder Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Post-Traumatic Stress Disorder Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Post-Traumatic Stress Disorder Treatment Market Share by Region (2019-2024)
Table 9. Global Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Post-Traumatic Stress Disorder Treatment Market Share by Region (2025-2030)
Table 11. Post-Traumatic Stress Disorder Treatment Market Trends
Table 12. Post-Traumatic Stress Disorder Treatment Market Drivers
Table 13. Post-Traumatic Stress Disorder Treatment Market Challenges
Table 14. Post-Traumatic Stress Disorder Treatment Market Restraints
Table 15. Global Post-Traumatic Stress Disorder Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Post-Traumatic Stress Disorder Treatment Market Share by Players (2019-2024)
Table 17. Global Top Post-Traumatic Stress Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder Treatment as of 2023)
Table 18. Ranking of Global Top Post-Traumatic Stress Disorder Treatment Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Post-Traumatic Stress Disorder Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Post-Traumatic Stress Disorder Treatment Product Solution and Service
Table 22. Date of Enter into Post-Traumatic Stress Disorder Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Post-Traumatic Stress Disorder Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Post-Traumatic Stress Disorder Treatment Revenue Market Share by Type (2019-2024)
Table 26. Global Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Post-Traumatic Stress Disorder Treatment Revenue Market Share by Type (2025-2030)
Table 28. Global Post-Traumatic Stress Disorder Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Post-Traumatic Stress Disorder Treatment Revenue Market Share by Application (2019-2024)
Table 30. Global Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Post-Traumatic Stress Disorder Treatment Revenue Market Share by Application (2025-2030)
Table 32. North America Post-Traumatic Stress Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Post-Traumatic Stress Disorder Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Post-Traumatic Stress Disorder Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Post-Traumatic Stress Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Post-Traumatic Stress Disorder Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Post-Traumatic Stress Disorder Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Post-Traumatic Stress Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Post-Traumatic Stress Disorder Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Post-Traumatic Stress Disorder Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 47. Pfizer, Inc. Company Detail
Table 48. Pfizer, Inc. Business Overview
Table 49. Pfizer, Inc. Post-Traumatic Stress Disorder Treatment Product
Table 50. Pfizer, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024) & (US$ Million)
Table 51. Pfizer, Inc. Recent Development
Table 52. GlaxoSmithKline plc Company Detail
Table 53. GlaxoSmithKline plc Business Overview
Table 54. GlaxoSmithKline plc Post-Traumatic Stress Disorder Treatment Product
Table 55. GlaxoSmithKline plc Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024) & (US$ Million)
Table 56. GlaxoSmithKline plc Recent Development
Table 57. Otsuka Pharmaceutical Co., Ltd Company Detail
Table 58. Otsuka Pharmaceutical Co., Ltd Business Overview
Table 59. Otsuka Pharmaceutical Co., Ltd Post-Traumatic Stress Disorder Treatment Product
Table 60. Otsuka Pharmaceutical Co., Ltd Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024) & (US$ Million)
Table 61. Otsuka Pharmaceutical Co., Ltd Recent Development
Table 62. Novartis AG Company Detail
Table 63. Novartis AG Business Overview
Table 64. Novartis AG Post-Traumatic Stress Disorder Treatment Product
Table 65. Novartis AG Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024) & (US$ Million)
Table 66. Novartis AG Recent Development
Table 67. AstraZeneca Plc Company Detail
Table 68. AstraZeneca Plc Business Overview
Table 69. AstraZeneca Plc Post-Traumatic Stress Disorder Treatment Product
Table 70. AstraZeneca Plc Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024) & (US$ Million)
Table 71. AstraZeneca Plc Recent Development
Table 72. Azevan Pharmaceuticals, Inc. Company Detail
Table 73. Azevan Pharmaceuticals, Inc. Business Overview
Table 74. Azevan Pharmaceuticals, Inc. Post-Traumatic Stress Disorder Treatment Product
Table 75. Azevan Pharmaceuticals, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024) & (US$ Million)
Table 76. Azevan Pharmaceuticals, Inc. Recent Development
Table 77. Bionomics Ltd. Company Detail
Table 78. Bionomics Ltd. Business Overview
Table 79. Bionomics Ltd. Post-Traumatic Stress Disorder Treatment Product
Table 80. Bionomics Ltd. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024) & (US$ Million)
Table 81. Bionomics Ltd. Recent Development
Table 82. Tonix Pharmaceuticals Holding Corp. Company Detail
Table 83. Tonix Pharmaceuticals Holding Corp. Business Overview
Table 84. Tonix Pharmaceuticals Holding Corp. Post-Traumatic Stress Disorder Treatment Product
Table 85. Tonix Pharmaceuticals Holding Corp. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024) & (US$ Million)
Table 86. Tonix Pharmaceuticals Holding Corp. Recent Development
Table 87. Apotex, Inc. Company Detail
Table 88. Apotex, Inc. Business Overview
Table 89. Apotex, Inc. Post-Traumatic Stress Disorder Treatment Product
Table 90. Apotex, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024) & (US$ Million)
Table 91. Apotex, Inc. Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Post-Traumatic Stress Disorder Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Post-Traumatic Stress Disorder Treatment Market Share by Type: 2023 VS 2030
Figure 3. Antidepressants Features
Figure 4. Anti-Anxiety Drugs Features
Figure 5. Others Features
Figure 6. Global Post-Traumatic Stress Disorder Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Post-Traumatic Stress Disorder Treatment Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Post-Traumatic Stress Disorder Treatment Report Years Considered
Figure 12. Global Post-Traumatic Stress Disorder Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Post-Traumatic Stress Disorder Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Post-Traumatic Stress Disorder Treatment Market Share by Region: 2023 VS 2030
Figure 15. Global Post-Traumatic Stress Disorder Treatment Market Share by Players in 2023
Figure 16. Global Top Post-Traumatic Stress Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder Treatment as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Post-Traumatic Stress Disorder Treatment Revenue in 2023
Figure 18. North America Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Post-Traumatic Stress Disorder Treatment Market Share by Country (2019-2030)
Figure 20. United States Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Post-Traumatic Stress Disorder Treatment Market Share by Country (2019-2030)
Figure 24. Germany Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Share by Region (2019-2030)
Figure 32. China Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Post-Traumatic Stress Disorder Treatment Market Share by Country (2019-2030)
Figure 40. Mexico Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Share by Country (2019-2030)
Figure 44. Turkey Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Pfizer, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
Figure 47. GlaxoSmithKline plc Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
Figure 48. Otsuka Pharmaceutical Co., Ltd Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
Figure 49. Novartis AG Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
Figure 50. AstraZeneca Plc Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
Figure 51. Azevan Pharmaceuticals, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
Figure 52. Bionomics Ltd. Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
Figure 53. Tonix Pharmaceuticals Holding Corp. Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
Figure 54. Apotex, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Table 1. Global Post-Traumatic Stress Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antidepressants
Table 3. Key Players of Anti-Anxiety Drugs
Table 4. Key Players of Others
Table 5. Global Post-Traumatic Stress Disorder Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Post-Traumatic Stress Disorder Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Post-Traumatic Stress Disorder Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Post-Traumatic Stress Disorder Treatment Market Share by Region (2019-2024)
Table 9. Global Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Post-Traumatic Stress Disorder Treatment Market Share by Region (2025-2030)
Table 11. Post-Traumatic Stress Disorder Treatment Market Trends
Table 12. Post-Traumatic Stress Disorder Treatment Market Drivers
Table 13. Post-Traumatic Stress Disorder Treatment Market Challenges
Table 14. Post-Traumatic Stress Disorder Treatment Market Restraints
Table 15. Global Post-Traumatic Stress Disorder Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Post-Traumatic Stress Disorder Treatment Market Share by Players (2019-2024)
Table 17. Global Top Post-Traumatic Stress Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder Treatment as of 2023)
Table 18. Ranking of Global Top Post-Traumatic Stress Disorder Treatment Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Post-Traumatic Stress Disorder Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Post-Traumatic Stress Disorder Treatment Product Solution and Service
Table 22. Date of Enter into Post-Traumatic Stress Disorder Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Post-Traumatic Stress Disorder Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Post-Traumatic Stress Disorder Treatment Revenue Market Share by Type (2019-2024)
Table 26. Global Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Post-Traumatic Stress Disorder Treatment Revenue Market Share by Type (2025-2030)
Table 28. Global Post-Traumatic Stress Disorder Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Post-Traumatic Stress Disorder Treatment Revenue Market Share by Application (2019-2024)
Table 30. Global Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Post-Traumatic Stress Disorder Treatment Revenue Market Share by Application (2025-2030)
Table 32. North America Post-Traumatic Stress Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Post-Traumatic Stress Disorder Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Post-Traumatic Stress Disorder Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Post-Traumatic Stress Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Post-Traumatic Stress Disorder Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Post-Traumatic Stress Disorder Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Post-Traumatic Stress Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Post-Traumatic Stress Disorder Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Post-Traumatic Stress Disorder Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 47. Pfizer, Inc. Company Detail
Table 48. Pfizer, Inc. Business Overview
Table 49. Pfizer, Inc. Post-Traumatic Stress Disorder Treatment Product
Table 50. Pfizer, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024) & (US$ Million)
Table 51. Pfizer, Inc. Recent Development
Table 52. GlaxoSmithKline plc Company Detail
Table 53. GlaxoSmithKline plc Business Overview
Table 54. GlaxoSmithKline plc Post-Traumatic Stress Disorder Treatment Product
Table 55. GlaxoSmithKline plc Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024) & (US$ Million)
Table 56. GlaxoSmithKline plc Recent Development
Table 57. Otsuka Pharmaceutical Co., Ltd Company Detail
Table 58. Otsuka Pharmaceutical Co., Ltd Business Overview
Table 59. Otsuka Pharmaceutical Co., Ltd Post-Traumatic Stress Disorder Treatment Product
Table 60. Otsuka Pharmaceutical Co., Ltd Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024) & (US$ Million)
Table 61. Otsuka Pharmaceutical Co., Ltd Recent Development
Table 62. Novartis AG Company Detail
Table 63. Novartis AG Business Overview
Table 64. Novartis AG Post-Traumatic Stress Disorder Treatment Product
Table 65. Novartis AG Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024) & (US$ Million)
Table 66. Novartis AG Recent Development
Table 67. AstraZeneca Plc Company Detail
Table 68. AstraZeneca Plc Business Overview
Table 69. AstraZeneca Plc Post-Traumatic Stress Disorder Treatment Product
Table 70. AstraZeneca Plc Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024) & (US$ Million)
Table 71. AstraZeneca Plc Recent Development
Table 72. Azevan Pharmaceuticals, Inc. Company Detail
Table 73. Azevan Pharmaceuticals, Inc. Business Overview
Table 74. Azevan Pharmaceuticals, Inc. Post-Traumatic Stress Disorder Treatment Product
Table 75. Azevan Pharmaceuticals, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024) & (US$ Million)
Table 76. Azevan Pharmaceuticals, Inc. Recent Development
Table 77. Bionomics Ltd. Company Detail
Table 78. Bionomics Ltd. Business Overview
Table 79. Bionomics Ltd. Post-Traumatic Stress Disorder Treatment Product
Table 80. Bionomics Ltd. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024) & (US$ Million)
Table 81. Bionomics Ltd. Recent Development
Table 82. Tonix Pharmaceuticals Holding Corp. Company Detail
Table 83. Tonix Pharmaceuticals Holding Corp. Business Overview
Table 84. Tonix Pharmaceuticals Holding Corp. Post-Traumatic Stress Disorder Treatment Product
Table 85. Tonix Pharmaceuticals Holding Corp. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024) & (US$ Million)
Table 86. Tonix Pharmaceuticals Holding Corp. Recent Development
Table 87. Apotex, Inc. Company Detail
Table 88. Apotex, Inc. Business Overview
Table 89. Apotex, Inc. Post-Traumatic Stress Disorder Treatment Product
Table 90. Apotex, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2019-2024) & (US$ Million)
Table 91. Apotex, Inc. Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Post-Traumatic Stress Disorder Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Post-Traumatic Stress Disorder Treatment Market Share by Type: 2023 VS 2030
Figure 3. Antidepressants Features
Figure 4. Anti-Anxiety Drugs Features
Figure 5. Others Features
Figure 6. Global Post-Traumatic Stress Disorder Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Post-Traumatic Stress Disorder Treatment Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Post-Traumatic Stress Disorder Treatment Report Years Considered
Figure 12. Global Post-Traumatic Stress Disorder Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Post-Traumatic Stress Disorder Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Post-Traumatic Stress Disorder Treatment Market Share by Region: 2023 VS 2030
Figure 15. Global Post-Traumatic Stress Disorder Treatment Market Share by Players in 2023
Figure 16. Global Top Post-Traumatic Stress Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder Treatment as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Post-Traumatic Stress Disorder Treatment Revenue in 2023
Figure 18. North America Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Post-Traumatic Stress Disorder Treatment Market Share by Country (2019-2030)
Figure 20. United States Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Post-Traumatic Stress Disorder Treatment Market Share by Country (2019-2030)
Figure 24. Germany Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Share by Region (2019-2030)
Figure 32. China Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Post-Traumatic Stress Disorder Treatment Market Share by Country (2019-2030)
Figure 40. Mexico Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Share by Country (2019-2030)
Figure 44. Turkey Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Pfizer, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
Figure 47. GlaxoSmithKline plc Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
Figure 48. Otsuka Pharmaceutical Co., Ltd Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
Figure 49. Novartis AG Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
Figure 50. AstraZeneca Plc Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
Figure 51. Azevan Pharmaceuticals, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
Figure 52. Bionomics Ltd. Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
Figure 53. Tonix Pharmaceuticals Holding Corp. Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
Figure 54. Apotex, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232